Erratum: Employing Macrophage-Derived Microvesicle for Kidney-Targeted Delivery of Dexamethasone: An Efficient Therapeutic Strategy against Renal Inflammation and Fibrosis: Erratum

Theranostics. 2023 Jan 9;13(2):870. doi: 10.7150/thno.78981. eCollection 2023.

Authors

Tao-Tao Tang¹, Lin-Li Lv¹, Bin Wang¹, Jing-Yuan Cao¹, Ye Feng¹, Zuo-Lin Li¹, Min Wu¹, Feng-Mei Wang¹, Yi Wen¹, Le-Ting Zhou¹, Hai-Feng Ni¹, Ping-Sheng Chen¹, Ning Gu², Steven D Crowley³, Bi-Cheng Liu^{1

2

3}

Affiliations

¹ Institute of Nephrology, Zhong Da Hospital, School of Medicine, Southeast University, Nanjing, China.
² State Key Laboratory of Bioelectronics, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Sciences and Medical Engineering, Southeast University, Nanjing, China.
³ Division of Nephrology, Department of Medicine, Duke University and Durham VA Medical Centers, Durham, North Carolina, United States.

Abstract

[This corrects the article DOI: 10.7150/thno.33520.].

© The author(s).

Publication types

Published Erratum